Organigram Global (TSX:OGI) is catching fresh attention after its addition to the S&P Global BMI Index, a move that often sparks added interest from institutional investors and index-tracking funds.

Pablo Zuanic, analyst at Cantor Fitzgerald, offered an updated investment model for OrganiGram (TSE: OGI) (NASDAQ:OGI) for which he maintained an Overweight but lowered the 12-month price target for ...

Organigram Global (TSX:OGI) just released its full year 2025 results, reporting sharply higher sales and revenue alongside a smaller net loss, and paired those figures with upbeat 2026 revenue and ...

I have been bullish on Organigram for quite some time, but it has dropped significantly. The stock is ridiculously cheap in my view. I expect that the stock can more than double over the next year. In ...

Organigram Global's estimated fair value is CA$5.45 based on 2 Stage Free Cash Flow to Equity Current share price of CA$2.74 suggests Organigram Global is potentially 50% undervalued Our fair value ...

Organigram stock has performed well this year, despite an equity raise and a temporary pullback caused by Tilray's poor financial report. The fiscal Q1 report showed a revenue shortfall, particularly ...